Verisk Analytics (VRSK) has undergone significant financial transactions and market fluctuations. Notable investors like
Bank of New York Mellon Corp and
Barclays have maintained a substantial stake, while others like
AlphaQuest LLC and
Allstate Corp have recently increased their holdings. Despite a 20.3% one-year total return decline and mixed performance, many retain a positive outlook, with Wall Street consensus giving Verisk a Moderate Buy rating. However, slower revenue growth and shift of investors to more cyclical sectors impacted Verisk's Q3 performance. Interesting to note, Verisk's partnership with
Earnix opened up possibilities in automating insurance compliance. Nevertheless, some like Navera Investment Management Ltd. have still invested heavily, indicating potential for growth. Despite
mixed performance, profound decreases in Q3 following a strong first half, and a negative sentiment, experts suggest Verisk is a strong growth stock, projected to grow its bottom lines. Its
cyber data tie-ups and deal with AccuLynx have changed its investment story. But with its stock trading lower, the question of valuation becomes central. Reports indicate a bearish sentiment due to Verisk's margin decline, and yet others argue it’s trading below fair value. Lastly, Verisk decided to sell its marketing solutions business to ActiveProspect, signalling a refocus on core insurance analytics.
Verisk Analytics VRSK News Analytics from Tue, 10 Jun 2025 07:00:00 GMT to Sat, 31 Jan 2026 10:31:34 GMT -
Rating 0
- Innovation 0
- Information 4
- Rumor -3
